Press Releases

Press Releases

XOMA Presents Advantages of Its Multiple Antibody Formulation Technologies at Antibody Engineering Conference

Dec 10, 2009 9:00am EST

XOMA Announces NASDAQ Matter Resolved With Letter of Reprimand

Dec 09, 2009 10:15am EST

XOMA Receives NASDAQ Determination Letter

Nov 19, 2009 4:09pm EST

XOMA Appoints Jim Neal Vice President of Business Development

Nov 17, 2009 8:00am EST

XOMA 052 Selected as a Top Ten Project to Watch

Nov 12, 2009 3:17pm EST

XOMA Announces Presentation at Lazard Healthcare Conference on November 18

Nov 11, 2009 2:30pm EST

XOMA Reports 2009 Third Quarter Financial Results

Nov 09, 2009 8:00am EST

XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases

Nov 06, 2009 8:00am EST

Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patients

Nov 04, 2009 8:00am EST

XOMA Granted First European Patent Covering XOMA 052

Nov 04, 2009 8:00am EST

1...
32
33
34
35
36
37
38
39
40
41
...47